NMD4C Launch Third Annual Training Series for Clinical Neuromuscular Fellows
The NMD4C Clinical Research Curriculum Development team is pleased to share that the third annual National Neuromuscular Lecture Series began this past August.
The NNLS is a year-long educational curriculum that provides training for clinical fellows enrolled in a Canadian neuromuscular fellowship program. The curriculum provides lectures from national experts in 32 key neuromuscular topics, developed in consultation with the directors of fellowship programs across Canada. The lecture series is designed to offer neuromuscular fellows at Canadian institutions the chance to learn from experts in different disciplines of neuromuscular medicine and forge connections with senior clinicians and investigators from across the country. The NNLS is approved by the Royal College of Physicians and Surgeons as a group learning activity as defined by the Maintenance of Certification Program, and fellows who attend over 75% of the lectures receive a certificate of attendance from the NMD4C.
In addition to lectures, this year’s program will also offer further engagement opportunities for participants as we introduce novel sessions in the form of journal club discussions, case presentations, and debates on emerging topics in neuromuscular medicine. The NNLS also offers opportunities for former fellows to stay involved in educational initiatives, and we are pleased to welcome Drs. Marianne Nury, Alasdair Rathbone, Issa Alawneh, Amanda Yaworski, Mona Hnaini, and Djurdja Djordjevic as moderators for this year’s program! They are joined by senior clinicians Drs. Alberto Aleman, Hernan Gonorazky, Erin O’Ferrall, Shahin Khayambashi and Jessica Theriault.
To learn more about the lecture series, please contact NNLS lead Dr. Alberto Aleman, or NDM4C Training and Curriculum coordinator Victoria Larocca.
Read next...
New Publication from the NMD4C Clinical Trial Network Strengthens Trial Capacity in Canada
We are pleased to share a new publication from the NMD4C Clinical Trial Network led by Kerri Lynn Schellenberg, Homira Osman, Maria Masnata, Rhiannon Hicks, Corinne Kagan, Ana Stosic, Stacey Lintern, Erin Beattie, Drs. Hanns Lochmüller, Craig Campbell, and Jean K Mah. This work focuses on the implementation of a coordinated Canadian neuromuscular clinical trial network to enhance trial readiness, capacity, and access in rare disease research.
Canadian-Led Phase II Studies Advance Vamorolone Evidence in Duchenne Muscular Dystrophy
NMD4C investigators contributed to two phase II studies evaluating vamorolone in boys with Duchenne muscular dystrophy across early childhood and adolescence, demonstrating safety, favorable pharmacokinetics, and potential efficacy. Led by Dr. Jean Mah and conducted across Canadian clinical trial sites with national and industry collaborators, the findings supported Health Canada approval of vamorolone as the first treatment for DMD in Canada. Leaders from both the clinical and patient advocacy communities, including Defeat Duchenne Canada, highlighted the impact of collaboration among patients, families, clinicians, and researchers in advancing care and improving access to new therapies.
Advancing AFC in Neuromuscular Medicine: Program Launch & September Workshop
The Royal College has approved National Training Standards for the AFC in Neuromuscular Medicine, creating a formal pathway to recognize enhanced competence with the DRCPSC credential. This designation establishes a national training standard, supports portable certification, and strengthens clinical capacity across Canada. PGME offices can now apply to offer accredited AFC programs, with a goal of five programs submitting applications by the end of 2026.